ロード中...
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors of the digestive system and has high morbidity and mortality rates. It is essential to search new biomarkers to improve the accuracy of early HCC diagnosis. Therefore, we evaluated the diagnostic value of prothromb...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8045263/ https://ncbi.nlm.nih.gov/pubmed/33849479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08138-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|